1. Home
  2. YEXT vs PRLD Comparison

YEXT vs PRLD Comparison

Compare YEXT & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yext Inc.

YEXT

Yext Inc.

HOLD

Current Price

$3.83

Market Cap

397.0M

Sector

Technology

ML Signal

HOLD

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

HOLD

Current Price

$4.19

Market Cap

346.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YEXT
PRLD
Founded
2006
2016
Country
United States
United States
Employees
N/A
79
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
397.0M
346.5M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
YEXT
PRLD
Price
$3.83
$4.19
Analyst Decision
Buy
Strong Buy
Analyst Count
4
3
Target Price
$7.50
$5.67
AVG Volume (30 Days)
1.3M
266.0K
Earning Date
06-02-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
131.82
23.21
EPS
0.02
N/A
Revenue
$170,201,000.00
$12,140,000.00
Revenue This Year
$3.95
$320.10
Revenue Next Year
$2.46
$100.00
P/E Ratio
$198.25
N/A
Revenue Growth
N/A
73.43
52 Week Low
$3.27
$0.75
52 Week High
$9.20
$5.54

Technical Indicators

Market Signals
Indicator
YEXT
PRLD
Relative Strength Index (RSI) 46.00 50.78
Support Level $3.66 $3.92
Resistance Level $4.14 $5.43
Average True Range (ATR) 0.24 0.34
MACD -0.00 0.05
Stochastic Oscillator 40.15 62.79

Price Performance

Historical Comparison
YEXT
PRLD

About YEXT Yext Inc.

Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to approximately 200 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible. The company also makes search intelligent by helping to provide precise, accurate and current answers to location-based queries that are conducted across the web and mobile applications and voice and artificial intelligence, or AI, engines. The company derives the majority of its revenues from subscription services. Geographically, the company generates a majority of its revenue from North America and the rest from International markets.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.

Share on Social Networks: